
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Nutra Gp | LSE:ONG | London | Ordinary Share | GB00B3LXPB43 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
11/2/2011 08:25 | Brewins have aline of orders upto 5p !!!! lol | ![]() oakville | |
11/2/2011 08:22 | get ready for lift off! lol | ![]() equitydealer007 | |
11/2/2011 08:20 | ong has been in my watchlist and has been accumulating since then. | pennylane2 | |
11/2/2011 08:18 | I think they are both viable stocks now. Any volume with the limited shares and this will fly. Go Baby Go!!! | wilba | |
11/2/2011 08:14 | This is a better stock than SAR... | ![]() oakville | |
11/2/2011 08:12 | this could do another SAR 10p end of day | ![]() go_baby_go | |
11/2/2011 08:11 | Lol. Div the market cap by shares in issue = guestimate share price based on cash in bank. You then add theoretical intangibles values. GLA. Looking great. | wilba | |
11/2/2011 08:08 | LOL! Not very good at maths, ashtree! | ![]() double6 | |
11/2/2011 08:07 | The market cap for this company is about 18.7 million.please check yourselves 62million shares x 3p.good luck. | ![]() ashtree2 | |
11/2/2011 08:05 | It's on the radar now and on it's way up. | ![]() 22hoper | |
11/2/2011 08:02 | Anyone got open sp? | vicehoudini2 | |
11/2/2011 08:01 | Spike??? We are nowhere near 6p yet !! | ![]() oakville | |
11/2/2011 07:58 | Depends on your definition of a little is...! Will see how it opens might put a grand in and check back at lunch seems to be a bit of interest and a strong close yesterday does bode well. | vicehoudini2 | |
11/2/2011 07:56 | Hi Wilba, then potential here is mind-blowing. What a great product and the world wide patent. | ![]() 22hoper | |
11/2/2011 07:51 | A little means in and little risk. Dont go mad but take part. NAI, DYOR. | wilba | |
11/2/2011 07:46 | To buy or not to buy....hmmmmm....don | vicehoudini2 | |
11/2/2011 07:43 | Morning all. Looks good from the stats. | wilba | |
11/2/2011 07:19 | ONG "MARY Poppins once sang that a spoonful of sugar helps the medicine go down. Now an Oxfordshire biotech firm has set out to prove her right by developing a new form of a common painkiller that tastes a lot sweeter. Researchers at Oxford Nutrascience have been working on ways of making ibuprofen more palatable by cutting out the burning sensation it sends to the throat and replacing it with more pleasant flavours. Now the company, which span out of the chemistry department of Oxford University in 2008, has signed a licensing agreement with Isis Innovation, the university's technology transfer company, to develop and commercialise the technology. As a result, the first ibuprofen "chews" and liquid could be on the market as early as next year. Marcelo Bravo, executive chairman and chief technology officer at Oxford Nutrascience, said: "Ibuprofen has been around a long time but delivers a burning sensation to the throat. "Using this technology we can deliver chewable and liquid forms of the drug using much higher doses suitable for some treatment needs and now we are working out how to take this to an industrial level." The potential of the breakthrough is huge. Mr Bravo said the current market for ibuprofen, originally invented by chemists at Boots, was £1.5bn a year. He added that manufacturers of ibuprofen had been "very enthusiastic" about the development which could lead to different flavours being used in different markets depending on local tastes. "The response has been outstanding. We are talking to the top five people in the world right now - it is a question of execution. "The regulatory experts are still quite complex but we are aiming to have a licence for early products some time in 2012." Oxford Nutrascience based at the Begbroke Innovation Centre, Yarnton, has a staff of four but uses a wide range of research partners to develop its technology. As well as ibuprofen, the company is developing new its taste-masking technology for a range of products, including fish oil and calcium supplements." | ![]() oakville | |
11/2/2011 07:15 | I wonder how the MM's will open procedings? | ![]() oakville | |
11/2/2011 07:14 | Good morning to anybody bothered to trade ONG.. | ![]() oakville | |
10/2/2011 21:15 | Can anyone answer this for me please? the company have c 464,000,000 shares issued with only 62.86m issued to the public. The rest are owned by private equity and the board. These shares are "locked in" until 12th February 2011 when they can be traded on the open market. The company website Market Cap is £13.36m (including the full issue). Considering the private equity investment was £1.039m might they be looking for an early return. I'm not sure what I'm asking really but could someone more knowledgable than me confirm or rubbish my assumptions? TIA | sp2 | |
10/2/2011 21:00 | oakville The cash of £1.28m and mkt cap of £1.81m (not checked) make this quite interesting regardless. Good luck and i wish you well. | ![]() 7bore | |
10/2/2011 20:49 | This is where we work.... See you lot in the early hours !! | ![]() oakville | |
10/2/2011 20:48 | 7bore I knew that would sway you !!! LOL Good Luck if you dip your toe in.. | ![]() oakville |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions